JP2014532402A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532402A5
JP2014532402A5 JP2014537726A JP2014537726A JP2014532402A5 JP 2014532402 A5 JP2014532402 A5 JP 2014532402A5 JP 2014537726 A JP2014537726 A JP 2014537726A JP 2014537726 A JP2014537726 A JP 2014537726A JP 2014532402 A5 JP2014532402 A5 JP 2014532402A5
Authority
JP
Japan
Prior art keywords
construct
aadc
viral
item
promoter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014537726A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014532402A (ja
JP6296987B2 (ja
Filing date
Publication date
Priority claimed from GBGB1118636.8A external-priority patent/GB201118636D0/en
Application filed filed Critical
Publication of JP2014532402A publication Critical patent/JP2014532402A/ja
Publication of JP2014532402A5 publication Critical patent/JP2014532402A5/ja
Application granted granted Critical
Publication of JP6296987B2 publication Critical patent/JP6296987B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014537726A 2011-10-28 2012-10-26 構築物 Active JP6296987B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161552581P 2011-10-28 2011-10-28
GB1118636.8 2011-10-28
US61/552,581 2011-10-28
GBGB1118636.8A GB201118636D0 (en) 2011-10-28 2011-10-28 Nucleotide sequence
PCT/GB2012/052668 WO2013061076A1 (en) 2011-10-28 2012-10-26 Construct

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018027852A Division JP6698114B2 (ja) 2011-10-28 2018-02-20 構築物

Publications (3)

Publication Number Publication Date
JP2014532402A JP2014532402A (ja) 2014-12-08
JP2014532402A5 true JP2014532402A5 (enExample) 2015-11-12
JP6296987B2 JP6296987B2 (ja) 2018-03-20

Family

ID=45373567

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014537726A Active JP6296987B2 (ja) 2011-10-28 2012-10-26 構築物

Country Status (11)

Country Link
US (1) US11279954B2 (enExample)
EP (2) EP3219801B1 (enExample)
JP (1) JP6296987B2 (enExample)
CN (2) CN107523581B (enExample)
AU (1) AU2012328166B2 (enExample)
CA (2) CA2849241C (enExample)
DK (2) DK2771471T3 (enExample)
ES (2) ES2857003T3 (enExample)
GB (1) GB201118636D0 (enExample)
PL (2) PL2771471T3 (enExample)
WO (1) WO2013061076A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201322798D0 (en) 2013-12-20 2014-02-05 Oxford Biomedica Ltd Production system
SG10202007103TA (en) 2014-11-05 2020-09-29 Voyager Therapeutics Inc Aadc polynucleotides for the treatment of parkinson's disease
RU2018104098A (ru) * 2015-08-03 2019-09-06 Майодопа Лимитед Системный синтез и регуляция l-дофа
GB2562774A (en) * 2017-05-25 2018-11-28 Mcdonald Michael Genetic construct
JOP20190269A1 (ar) 2017-06-15 2019-11-20 Voyager Therapeutics Inc بولي نوكليوتيدات aadc لعلاج مرض باركنسون
MA52631A (fr) 2018-05-15 2021-03-24 Voyager Therapeutics Inc Compositions et méthodes pour le traitement de la maladie de parkinson
CN108841868A (zh) * 2018-05-31 2018-11-20 康霖生物科技(杭州)有限公司 一种用于中枢神经系统疾病治疗的基因序列构建体
JP7528066B2 (ja) 2018-09-28 2024-08-05 ボイジャー セラピューティクス インコーポレイテッド 操作されたプロモータを有するフラタキシン発現コンストラクトおよびその使用方法
CA3133188A1 (en) * 2019-03-10 2020-09-17 Oxford Biomedica (Uk) Limited Gene therapy compositions and methods for treating parkinson's disease
CN109971729B (zh) * 2019-04-19 2021-07-16 上海信致医药科技有限公司 一种酶组合物
GB2587319A (en) 2019-08-12 2021-03-31 Healing Genes Llc Genetic construct
CN118360338A (zh) * 2020-03-13 2024-07-19 康霖生物科技(杭州)有限公司 一种核酸构建体
GB2601752A (en) 2020-12-08 2022-06-15 Maavrx Ltd Expression vector
JP2024546964A (ja) 2021-12-17 2024-12-26 インペリアル カレッジ イノベイションズ リミテッド Rna構築物
CN114317610B (zh) * 2022-01-27 2024-07-02 上海本导基因技术有限公司 一种适用于帕金森疾病基因治疗的慢病毒载体
CN117106825B (zh) * 2023-08-28 2024-11-01 康霖生物科技(杭州)有限公司 用于治疗帕金森病的基因治疗载体及其用途
CN118389675B (zh) * 2024-05-27 2025-06-27 南方医科大学珠江医院 芳香族氨基酸脱羧酶作为标志物在肝性脑病的检测产品中的应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
DE4006630A1 (de) 1990-03-03 1991-09-12 Behringwerke Ag Humane monoklonale antikoerper gegen tollwutviren, ihre herstellung und verwendung
US5512421A (en) 1991-02-19 1996-04-30 The Regents Of The University Of California Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors
WO1993000314A1 (en) 1991-06-21 1993-01-07 Mobil Oil Corporation Method for increasing rainout from autorefrigerated vaporous cloud containing hydrofluoric acid
US6001650A (en) 1995-08-03 1999-12-14 Avigen, Inc. High-efficiency wild-type-free AAV helper functions
WO1997018319A1 (en) * 1995-11-14 1997-05-22 Somatix Therapy Corporation Joint expression of gtp cyclohydrolase and tyrosine hydroxylase
US5866552A (en) 1996-09-06 1999-02-02 The Trustees Of The University Of Pennsylvania Method for expressing a gene in the absence of an immune response
DE69703974T2 (de) 1996-10-17 2001-07-19 Oxford Biomedica (Uk) Ltd., Oxford Retrovirale vektoren
GB9622500D0 (en) * 1996-10-29 1997-01-08 Oxford Biomedica Ltd Therapeutic gene
GB9720465D0 (en) 1997-09-25 1997-11-26 Oxford Biomedica Ltd Dual-virus vectors
GB9803351D0 (en) 1998-02-17 1998-04-15 Oxford Biomedica Ltd Anti-viral vectors
ATE435297T1 (de) 1998-05-22 2009-07-15 Oxford Biomedica Ltd Retrovirales verabreichungssystem
GB9904905D0 (en) 1999-03-03 1999-04-28 Oxford Biomedica Ltd Cells
WO2001004433A1 (es) 1999-07-13 2001-01-18 Pellicer Carlos F Panel para la construccion e instalacion para su fabricacion
GB0009760D0 (en) 2000-04-19 2000-06-07 Oxford Biomedica Ltd Method
GB0024550D0 (enExample) * 2000-10-06 2000-11-22 Oxford Biomedica Ltd
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
PT1504108E (pt) 2002-02-01 2013-06-12 Oxford Biomedica Ltd Vetor lentiviral
SE0302509D0 (sv) 2003-09-19 2003-09-19 Amersham Biosciences Ab Matrix for separation of polyethers and method of separation
US7943374B2 (en) 2005-08-21 2011-05-17 Markus Hildinger Super-size adeno-associated viral vector harboring a recombinant genome larger than 5.7 kb
GB0526210D0 (en) 2005-12-22 2006-02-01 Oxford Biomedica Ltd Vectors
GB0526211D0 (en) 2005-12-22 2006-02-01 Oxford Biomedica Ltd Viral vectors
US20090214478A1 (en) 2008-02-21 2009-08-27 Alberto Auricchio Method of treating ocular diseases by gene therapy
US9169491B2 (en) 2008-06-18 2015-10-27 Oxford Biomedica (Uk) Limited Virus purification
US20110269826A1 (en) * 2008-11-11 2011-11-03 Oxford Biomedica (Uk) Limited Method
EP2575894B1 (en) * 2010-05-28 2015-02-25 Oxford Biomedica (UK) Ltd Delivery of lentiviral vectors to the brain

Similar Documents

Publication Publication Date Title
JP2014532402A5 (enExample)
JP2022031942A (ja) 広域インフルエンザウイルスワクチン
JP5432415B2 (ja) キャッピングプローンrnaポリメラーゼ酵素およびその適用
JP2016538830A5 (enExample)
KR20200083550A (ko) ACE-tRNA에 의한 유전자 재지정을 통해 정지 코돈을 구조하는 방법
JP2014500724A5 (enExample)
JP2017532966A5 (enExample)
JP2015513897A5 (enExample)
JP2017070289A5 (enExample)
JP2010530245A5 (enExample)
EP4582098A3 (en) Optimized nucleic acid molecules
JP2019517790A5 (enExample)
WO2010105251A3 (en) Non-integrating retroviral vector vaccines
JP2016501531A5 (enExample)
WO2018004308A3 (ko) 신규 내열성 과당-6-인산-3-에피머화 효소 및 이를 이용한 알룰로스 제조방법
JP2017538401A5 (enExample)
MX2019015502A (es) L-asparaginasa modificada.
JP2008056679A5 (enExample)
WO2008011120A3 (en) Human endogenous retrovirus polypeptide compositions and methods of use thereof
JP2019519529A5 (enExample)
JP2017524380A5 (ja) 腫瘍血管遮断剤であるポリペプチド、遺伝子、発現ベクター、腫瘍血管遮断剤の組成物、及び腫瘍血管遮断剤であるポリペプチドの調製方法
Aurélie et al. Lentiviral vectors: a powerful tool to target astrocytes in vivo
JP2019534884A5 (enExample)
JP2012529293A5 (enExample)
EP2527445A3 (en) Treatment and prevention of influenza